Outlook Wealth Advisors LLC has made a strategic investment in Intuitive Surgical, Inc., purchasing 396 shares of the medical equipment provider’s stock during the second quarter. The acquisition, outlined in the firm’s recent Form 13F filing with the U.S. Securities and Exchange Commission (SEC), is valued at approximately $215,000. This move comes as several other institutional investors and hedge funds have also adjusted their stakes in the company.
Tobam significantly increased its investment in Intuitive Surgical, raising its stake by 666.7% during the same period. The firm now owns 46 shares worth $25,000 after acquiring an additional 40 shares. Princeton Global Asset Management LLC entered a new position in Intuitive Surgical valued at around $30,000, while TD Capital Management LLC expanded its holdings by 300.0% in the first quarter, ultimately owning 60 shares now valued at $30,000. Additionally, Bank of Jackson Hole Trust raised its stake by 70.5%, holding 75 shares valued at approximately $37,000. Collectively, institutional investors own 83.64% of Intuitive Surgical’s stock.
In related news, insider trading activity at Intuitive Surgical has seen notable transactions. Gary S. Guthart, the company’s insider, sold 29,360 shares on August 29 at an average price of $472.49, totaling approximately $13.87 million. Following the sale, Guthart retained 19,827 shares, valued at about $9.37 million, reflecting a 59.69% decrease in his ownership.
Similarly, CEO David J. Rosa sold 24,500 shares on October 24 for an average price of $547.55, resulting in a total of $13.41 million. Post-transaction, Rosa holds 234,256 shares, valued at approximately $128.27 million, marking a 9.47% decrease in his position. Over the past ninety days, insiders have sold 116,164 shares worth $61.92 million, with corporate insiders owning 0.70% of the company’s stock.
Intuitive Surgical’s Performance and Analyst Outlook
On Wednesday, shares of Intuitive Surgical opened at $546.77. The company’s 50-day moving average stands at $485.63 while the 200-day moving average is $503.34. The stock has experienced a one-year low of $425.00 and a high of $616.00. Intuitive Surgical boasts a market capitalization of $196.00 billion, a price-to-earnings ratio of 72.32, and a beta of 1.62.
Intuitive Surgical recently reported its earnings results for the third quarter on October 21. The company achieved earnings per share of $2.40, exceeding analysts’ consensus estimates of $1.99 by $0.41. The business reported revenue of $2.51 billion, surpassing the consensus estimate of $2.41 billion. This marks a year-over-year revenue increase of 22.9%, compared to $1.84 earnings per share during the same period last year. Analysts project Intuitive Surgical will post an EPS of 6.43 for the current fiscal year.
Intuitive Surgical, Inc. engages in the development, manufacturing, and marketing of products that enhance minimally invasive care for healthcare providers. The company is well-known for its da Vinci Surgical System, which facilitates complex surgeries through a minimally invasive approach, as well as the Ion endoluminal system, which expands its offerings into diagnostic procedures.
For those interested in further insights, additional details about hedge fund holdings and insider trades related to Intuitive Surgical can be accessed through financial news platforms.
